Compile Data Set for Download or QSAR
Report error Found 30 Enz. Inhib. hit(s) with all data for entry = 50035418 Sort by
TargetCaspase-9(Human)
Maxim Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50140543(3-((S)-2-Benzyloxycarbonylamino-3-methyl-butyrylam...)
Affinity DataIC50: 5nMAssay Description:Compound was evaluated for its inhibitory activity against the Caspase-9 enzymeMore data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetCaspase-8(Human)
Maxim Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50140543(3-((S)-2-Benzyloxycarbonylamino-3-methyl-butyrylam...)
Affinity DataIC50: 7nMAssay Description:Compound was evaluated for its inhibitory activity against the Caspase-8 enzymeMore data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetCaspase-7(Human)
Maxim Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50140543(3-((S)-2-Benzyloxycarbonylamino-3-methyl-butyrylam...)
Affinity DataIC50: 7nMAssay Description:Compound was evaluated for its inhibitory activity against the Caspase-7 enzymeMore data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetCaspase-6(Human)
Maxim Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50140543(3-((S)-2-Benzyloxycarbonylamino-3-methyl-butyrylam...)
Affinity DataIC50: 18nMAssay Description:Compound was evaluated for its inhibitory activity against the Caspase-6 enzymeMore data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetCaspase-1(Human)
Maxim Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50140543(3-((S)-2-Benzyloxycarbonylamino-3-methyl-butyrylam...)
Affinity DataIC50: 20nMAssay Description:Compound was evaluated for its inhibitory activity against the Caspase-1 enzymeMore data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetCaspase-3(Human)
Maxim Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50140543(3-((S)-2-Benzyloxycarbonylamino-3-methyl-butyrylam...)
Affinity DataIC50: 30nMAssay Description:Inhibitory activity against human recombinant Caspase-3 enzymeMore data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetCaspase-3(Human)
Maxim Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50366934(CHEMBL1794026)
Affinity DataIC50: 70nMAssay Description:Inhibitory activity against human recombinant Caspase-3 enzymeMore data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetCaspase-3(Human)
Maxim Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50140549(3-((S)-2-Benzyloxycarbonylamino-2-cyclohexyl-acety...)
Affinity DataIC50: 100nMAssay Description:Inhibitory activity against human recombinant Caspase-3 enzymeMore data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetCaspase-3(Human)
Maxim Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50140551(3-((S)-2-Benzyloxycarbonylamino-2-phenyl-acetylami...)
Affinity DataIC50: 100nMAssay Description:Inhibitory activity against human recombinant Caspase-3 enzymeMore data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetCaspase-3(Human)
Maxim Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50140552(3-((S)-2-Benzyloxycarbonylamino-butyrylamino)-5-fl...)
Affinity DataIC50: 100nMAssay Description:Inhibitory activity against human recombinant Caspase-3 enzymeMore data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetCalpain-1 catalytic subunit(Human)
Maxim Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50140548(3-((S)-2-Benzyloxycarbonylamino-3-methyl-butyrylam...)
Affinity DataIC50: 120nMAssay Description:Compound was evaluated for its inhibitory activity against the Calpain-1 enzymeMore data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetCaspase-3(Human)
Maxim Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50140550(3-((S)-2-Benzyloxycarbonylamino-3-thiophen-2-yl-pr...)
Affinity DataIC50: 150nMAssay Description:Inhibitory activity against human recombinant Caspase-3 enzymeMore data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetCaspase-3(Human)
Maxim Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50140544(3-((S)-2-Benzyloxycarbonylamino-4-methyl-pentanoyl...)
Affinity DataIC50: 200nMAssay Description:Inhibitory activity against human recombinant Caspase-3 enzymeMore data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetCathepsin B(Human)
Maxim Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50140548(3-((S)-2-Benzyloxycarbonylamino-3-methyl-butyrylam...)
Affinity DataIC50: 300nMAssay Description:Compound was evaluated for its inhibitory activity against Cathepsin BMore data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetCaspase-3(Human)
Maxim Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50140558(3-((S)-2-Benzyloxycarbonylamino-3-phenyl-propionyl...)
Affinity DataIC50: 400nMAssay Description:Inhibitory activity against human recombinant Caspase-3 enzymeMore data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetCaspase-3(Human)
Maxim Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50140546(3-((S)-2-Benzyloxycarbonylamino-propionylamino)-5-...)
Affinity DataIC50: 600nMAssay Description:Inhibitory activity against human recombinant Caspase-3 enzymeMore data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetCaspase-1(Human)
Maxim Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50140548(3-((S)-2-Benzyloxycarbonylamino-3-methyl-butyrylam...)
Affinity DataIC50: 900nMAssay Description:Compound was evaluated for its inhibitory activity against the Caspase-1 enzymeMore data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetCaspase-3(Human)
Maxim Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50140548(3-((S)-2-Benzyloxycarbonylamino-3-methyl-butyrylam...)
Affinity DataIC50: 1.10E+3nMAssay Description:Inhibitory activity against human recombinant Caspase-3 enzymeMore data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetCaspase-3(Human)
Maxim Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50140553(3-(2-Benzyloxycarbonylamino-2-methyl-propionylamin...)
Affinity DataIC50: 1.40E+3nMAssay Description:Inhibitory activity against human recombinant Caspase-3 enzymeMore data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetCaspase-3(Human)
Maxim Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50140557(3-((S)-6-Amino-2-benzyloxycarbonylamino-hexanoylam...)
Affinity DataIC50: 1.60E+3nMAssay Description:Inhibitory activity against human recombinant Caspase-3 enzymeMore data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetCaspase-3(Human)
Maxim Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50140556(3-(2-Benzyloxycarbonylamino-acetylamino)-5-fluoro-...)
Affinity DataIC50: 1.90E+3nMAssay Description:Inhibitory activity against human recombinant Caspase-3 enzymeMore data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetCaspase-3(Human)
Maxim Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50140554(3-(2-Benzyloxycarbonylamino-2,3-dimethyl-butyrylam...)
Affinity DataIC50: 2.30E+3nMAssay Description:Inhibitory activity against human recombinant Caspase-3 enzymeMore data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetCaspase-3(Human)
Maxim Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50366933(CHEMBL1794025)
Affinity DataIC50: 2.60E+3nMAssay Description:Inhibitory activity against human recombinant Caspase-3 enzymeMore data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetCalpain-1 catalytic subunit(Human)
Maxim Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50140543(3-((S)-2-Benzyloxycarbonylamino-3-methyl-butyrylam...)
Affinity DataIC50: 1.00E+4nMAssay Description:Compound was evaluated for its inhibitory activity against the Calpain 1 enzymeMore data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetCathepsin B(Human)
Maxim Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50140543(3-((S)-2-Benzyloxycarbonylamino-3-methyl-butyrylam...)
Affinity DataIC50: 1.00E+4nMAssay Description:Compound was evaluated for its inhibitory activity against Cathepsin BMore data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetCaspase-3(Human)
Maxim Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50140555(3-((S)-2-Benzyloxycarbonylamino-4-carboxy-butyryla...)
Affinity DataIC50: 1.40E+4nMAssay Description:Inhibitory activity against human recombinant Caspase-3 enzymeMore data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetProthrombin(Human)
Maxim Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50140548(3-((S)-2-Benzyloxycarbonylamino-3-methyl-butyrylam...)
Affinity DataIC50: 1.00E+5nMAssay Description:Compound was evaluated for its inhibitory activity against the ThrombinMore data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetCoagulation factor X(Human)
Maxim Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50140548(3-((S)-2-Benzyloxycarbonylamino-3-methyl-butyrylam...)
Affinity DataIC50: 1.00E+5nMAssay Description:Compound was evaluated for its inhibitory activity against the Coagulation factor XMore data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetCoagulation factor X(Human)
Maxim Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50140543(3-((S)-2-Benzyloxycarbonylamino-3-methyl-butyrylam...)
Affinity DataIC50: 1.00E+5nMAssay Description:Compound was evaluated for its inhibitory activity against the Coagulation factor XMore data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetProthrombin(Human)
Maxim Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50140543(3-((S)-2-Benzyloxycarbonylamino-3-methyl-butyrylam...)
Affinity DataIC50: 1.00E+5nMAssay Description:Compound was evaluated for its inhibitory activity against the ThrombinMore data for this Ligand-Target Pair
In DepthDetails Article
PubMed